These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3933225)

  • 1. [Production and study of the properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine. IV. The effect of immunization with Pseudomonas aeruginosa vaccine on the immune status of volunteer donors].
    Titova TI; Sidorova TN; Radkevich SA; Antsiferova NG; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):80-4. PubMed ID: 3933225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation and study of the properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine. An evaluation of the biological properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine].
    Ttitova TI; Grigor'ev NI; Antsiferova NG; Radkevich SA; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):14-8. PubMed ID: 3931392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia].
    Vetkova LG; Zaĭtsev LG; Khasman EL; Radkevich SA; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):14-8. PubMed ID: 3085409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of a polyvalent erythrocyte diagnostic agent for determining antibodies to Pseudomonas aeruginosa in clinical practice].
    Aleksandrova IA; Titova TI; Aleksandrov AD; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):46-50. PubMed ID: 2496541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Production and experimental testing of the polyvalency of corpuscular vaccine for the prevention of Pseudomonas aeruginosa infections II. Experimental testing of the immunogenicity of polyvalent corpuscular Pseudomonas aeruginosa vaccine].
    Moroz AF; Antsiferova NG; Radkevich SA; Mishina VS
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):74-80. PubMed ID: 6800165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immunological response in volunteer donors immunized with a Pseudomonas vaccine].
    Makarenko TA; Balaian SS; Sergienko AI; Stanislavskiĭ ES; Edvabnaia LS; Abramova IA; Krokhina MA; Rusanov VM
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Nov; (11):39-41. PubMed ID: 1811387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety and sensitizing properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine and its effect on hematological indices].
    Kharitonova AM; Grigor'eva LV; Antsiferova NG; Radkevich SA; Vetkova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):14-9. PubMed ID: 3083619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoenzyme analysis method for detecting anti-Pseudomonas aeruginosa antibodies in persons inoculated with pyoimmunogen].
    Severtsova MK; Vaĭda MB; Varró R
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jan; (1):55-9. PubMed ID: 3920846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Principle of constructing polyvalent Pseudomonas aeruginosa vaccines].
    Akatova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Feb; (2):56-60. PubMed ID: 84457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the anti-infection immunity indices of esophageal cancer patients undergoing combined immunization against staphylococcal and Pseudomonas aeruginosa infections].
    Kochetkova VA; Mamontov AS; Sokolova II; Mezhova OM; Morozov AF
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jun; (6):91-5. PubMed ID: 6810593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of a study of the safety, reactogenicity and immunologic effectiveness of pyoimmunogen in the immunization of volunteer donors].
    Krokhina MA; Grishina IA; Arkhipova NA; Zarubina EK; Edvabnaia LS
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):95-8. PubMed ID: 7331614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of a polyvalent erythrocyte diagnostic agent based on the antigens of Pseudomonas aeruginosa slime].
    Aleksandrova IA; Moroz AF; Antsiferova NG; Aleksandrov AD
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):72-5. PubMed ID: 3099518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Production of a hyperimmune antitoxic donor plasma against Pseudomonas aeruginosa].
    Krokhina MA; Davatdarova GM; Cherkas GP; Podgornaia LG; Shinkarenko AA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):78-83. PubMed ID: 6778040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective action of a corpuscular polyvalent Pseudomonas aeruginosa vaccine against representative enterobacteria].
    Vetkova LG; Antsiferova NG; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):26-30. PubMed ID: 2409719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of a polyvalent corpuscular Pseudomonas aeruginosa vaccine, antibiotics and their combinations in experimental chronic Pseudomonas aeruginosa infection].
    Vetkova LG; Antsiferova NG; Radkevich SA; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Mar; (3):51-6. PubMed ID: 3922187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine on the proliferation and differentiation of hematopoietic stem cells and erythropoiesis].
    Khorobrykh VV; Vetkova LG; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jan; (1):65-9. PubMed ID: 3085406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine.
    Zuercher AW; Imboden MA; Jampen S; Bosse D; Ulrich M; Chtioui H; Lauterburg BH; Lang AB
    Clin Exp Immunol; 2005 Nov; 142(2):381-7. PubMed ID: 16232228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
    Bruderer U; Cryz SJ; Schaad UB; Deusinger M; Que JU; Lang AB
    J Infect Dis; 1992 Aug; 166(2):344-9. PubMed ID: 1634805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral application of a Pseudomonas aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals.
    Döring G; Pfeiffer C; Weber U; Mohr-Pennert A; Dorner F
    Am J Respir Crit Care Med; 1995 Apr; 151(4):983-5. PubMed ID: 7697276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.